S. Francioso

发表

A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trial.

F. Santopaolo, M. Angelico, G. Parruti, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature

A. Orlacchio, T. Manzia, I. Lenci, 2019, Radiology case reports.

Attitudes and approach to cardiovascular risk factors in Italy: results of an electronic questionnaire survey.

S. Bagnara, M. del Ben, A. Mammarella, 2003, Public health.

Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases

C. Alessandri, T. Antonini, M. del Ben, 2003, Journal of gastroenterology and hepatology.

Evaluation of Liver Fibrosis in Cirrhotic Patients: Comparison between Elastoso- nography and Fibroscan

A. Orlacchio, F. Chegai, I. Lenci, 2019, jcap.

Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels.

I. Lenci, M. Angelico, S. Francioso, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Peginterferon &agr;-2a and ribavirin versus peginterferon &agr;-2a monotherapy in early virological responders and peginterferon &agr;-2a and ribavirin versus peginterferon &agr;-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with

L. Demelia, A. Grieco, M. Angelico, 2008, European journal of gastroenterology & hepatology.

Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma

A. Orlacchio, I. Lenci, S. Francioso, 2021, Journal of oncology.

Treatment with ribavirin and interferon‐α reduces interferon‐γ expression in patients with chronic hepatitis C

A. Bergamini, F. Bolacchi, G. Rocchi, 2001 .

Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study

A. Orlacchio, F. Chegai, S. Francioso, 2020, La radiologia medica.

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

F. Ceccherini‐Silberstein, V. Vullo, N. Caporaso, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro

Domenico Di Carlo, F. Ceccherini‐Silberstein, H. Fleury, 2017, Oncotarget.

The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.

F. Ceccherini‐Silberstein, H. Fleury, M. Levrero, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

M. Manns, F. Baldanti, F. Ceccherini‐Silberstein, 2020, Journal of hepatology.

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

A. Gasbarrini, F. Ceccherini‐Silberstein, V. Vullo, 2016, The Journal of antimicrobial chemotherapy.

A randomized controlled trial of amantadine plus interferon‐α2a vs. interferon‐α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon‐α2a monotherapy

L. Demelia, A. Tosti, A. Grieco, 2004, Alimentary pharmacology & therapeutics.

3609-3617-A retrospective analysis of 1.011 PLB performed in patients with liver transplantation or liver disease

G. Tisone, F. Santopaolo, D. Sforza, 2016 .

Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients

F. Violi, M. Carbone, M. del Ben, 2009, Alimentary pharmacology & therapeutics.

A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications?

G. Tisone, F. Santopaolo, D. Sforza, 2016, European review for medical and pharmacological sciences.

Repeated Transarterial Chemoembolization with Degradable Starch  Microspheres (DSMs-TACE) of Unresectable Hepatocellular Carcinoma: A Prospective Pilot Study

A. Orlacchio, F. Chegai, G. Tisone, 2017, Current medical imaging reviews.

Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization.

G. Simonetti, A. Orlacchio, F. Chegai, 2015, World journal of hepatology.

Liver elasticity in NASH patients evaluated with real-time elastography (RTE).

Giovanni Simonetti, G. Simonetti, A. Orlacchio, 2012, Ultrasound in medicine & biology.

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.

C. Alessandri, F. Violi, M. Cavallo, 2005, The Journal of clinical endocrinology and metabolism.

Recurrence of insulin resistant metabolic syndrome following liver transplantation.

G. Tisone, M. del Ben, M. Angelico, 2003, European journal of gastroenterology & hepatology.

Results of a fast-track referral system for urgent outpatient hepatology visits.

L. Baiocchi, I. Lenci, M. Milana, 2015, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Lack of reduction in serum alpha‐fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus‐related cirrhosis

A. Gasbarrini, M. Pompili, U. Visco-Comandini, 2018, Journal of viral hepatitis.

196 HIGH PREVALENCE OF METABOLIC SYNDROME AND LONG-TERM SURVIVAL AFTER LIVER TRANSPLANTATION

M. Carbone, G. Tisone, L. Baiocchi, 2008 .

Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers

G. Simonetti, A. Orlacchio, F. Chegai, 2016, La radiologia medica.

Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.

A. Bergamini, F. Bolacchi, G. Rocchi, 2001, Clinical and experimental immunology.

Liver elasticity in NASH patients evaluated with real-time elastography (RTE).

G. Simonetti, A. Orlacchio, F. Bolacchi, 2012, Ultrasound in medicine & biology.

L. Demelia, A. Grieco, M. Angelico, 2008, European journal of gastroenterology & hepatology.

Results of a fast-track referral system for urgent outpatient hepatology visits.

L. Baiocchi, I. Lenci, M. Milana, 2015, International journal for quality in health care : journal of the International Society for Quality in Health Care.